M. Bagnalasta

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Valentina Guarneri, Antonio Frassoldati, Alberto Bottini et al. · Journal of Clinical Oncology · 2012 · 368 citations · Full text

Medicine, Oncology, Pharmacology +16

Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats

Elaine E. Irvine, M. Bagnalasta, Clara Marcon et al. · Psychopharmacology · 2000 · 73 citations

Medicine, Behavioral Sciences, Pharmacology +14

Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial).

Valentina Guarneri, Antonio Frassoldati, Alberto Bottini et al. · Journal of Clinical Oncology · 2011 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17